NEW YORK (GenomeWeb News) – Beckman Coulter today said that its pending $780 million acquisition of the diagnostics business of Olympus has cleared US antitrust review by the Federal Trade Commission.

The firm said that it expects to close the deal in the third quarter of 2009, subject to certain additional conditions including approval from governments outside of the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.